Who invested in OncoPep?
OncoPep's investors include Leukemia & Lymphoma Society.
United States · Series D startup
5 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$25Mraised across 5 rounds since 2011, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Source recorded
From a historical funding recordSEC filing: $3.0M sold, first sale May 2014
No investor was named in the report.
Reported by masshightech.comSEC filing: $2.5M sold, first sale Apr 2011
No investor was named in the report.
Reported by masshightech.comSEC filing: $2.5M sold, first sale Apr 2011
No investor was named in the report.
Reported by masshightech.comSEC filing: $3.6M sold, first sale Apr 2011
OncoPep's investors include Leukemia & Lymphoma Society.
OncoPep has raised $25M across 5 rounds since 2011.
OncoPep's most recent round was a Series D of $11M in Dec 2021.
Its most recent round, $11M in Dec 2021, is also its largest on record.
OncoPep's first round on record, in Aug 2014, was backed by Leukemia & Lymphoma Society.
OncoPep's latest named round is a Series D, in Dec 2021.
OncoPep is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.